
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xml:lang="en-US"
               >
      <channel>
        <title>Latest articles from The Clinical Advisor Features</title>
        <link>http://feeds2.feedburner.com/clinicaladvisorfeatures</link>
        <description>Latest articles from The Clinical Advisor Features</description>
        
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
        <itunes:subtitle>Features</itunes:subtitle>
        <itunes:summary><![CDATA[]]></itunes:summary>
        <itunes:owner>
            <itunes:name>Features</itunes:name>
            <itunes:email>custserv@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="Business">
            <itunes:category text="Business News" /> 
        </itunes:category> 
        <itunes:image href='https://media.haymarketmedia.com/images/212/CA-logo_mobile_52754.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
          
          <atom:link href="http://feeds2.feedburner.com/clinicaladvisorfeatures" rel="self" type="application/rss+xml" />
  
        <item>
          
          <title>Opioid-Induced Constipation: Insights Into Diagnosis and Effective Treatment</title>
            
            
            <description>Conventional approaches to treatment of opioid-induced constipation include the use of treatment modalities that address non-opioid-related constipation as well as new medications that target the OIC mechanism of action.</description>
            
            <link>https://www.clinicaladvisor.com/diagnosis-and-effective-treatment-of-opioid-induced-constipation/article/832394/</link>
            <pubDate>Wed, 06 Feb 2019 17:03:02 GMT</pubDate>
            
          <itunes:summary>Conventional approaches to treatment of opioid-induced constipation include the use of treatment modalities that address non-opioid-related constipation as well as new medications that target the OIC mechanism of action.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/diagnosis-and-effective-treatment-of-opioid-induced-constipation/article/832394/</guid>
               
                                
        </item>
  
        <item>
          
          <title>ACIP Updates Recommendations for US Adult Immunization Schedule</title>
            
            
            <description>The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.</description>
            
            <link>https://www.clinicaladvisor.com/american-committee-on-immunization-practices-and-cdc-issue-vaccine-updates/article/832273/</link>
            <pubDate>Wed, 06 Feb 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>The ACIP and CDC have approved and released 2019 recommendations for the adult immunization schedule in the US.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/american-committee-on-immunization-practices-and-cdc-issue-vaccine-updates/article/832273/</guid>
               
                                
        </item>
  
        <item>
          
          <title>To Question, or Not to Question Your Supervisor&apos;s Diagnosis</title>
            
            
            <description>A nurse practitioner disagrees with her supervisor over a diagnosis but fails to voice her opinion, leading to misdiagnosis and a subsequent above-the-knee amputation.</description>
            
            <link>https://www.clinicaladvisor.com/legal-advisor-agreeing-with-supervisor-vs-advocating-for-patient/article/832275/</link>
            <pubDate>Wed, 06 Feb 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>A nurse practitioner disagrees with her supervisor over a diagnosis but fails to voice her opinion, leading to misdiagnosis and a subsequent above-the-knee amputation.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/legal-advisor-agreeing-with-supervisor-vs-advocating-for-patient/article/832275/</guid>
               
                                
        </item>
  
        <item>
          
          <title>In the Spotlight: How Racism Affects the Healthcare Workforce</title>
            
            
            <description>Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce?</description>
            
            <link>https://www.clinicaladvisor.com/racism-healthcare-workforce/article/830881/</link>
            <pubDate>Fri, 01 Feb 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce?</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/racism-healthcare-workforce/article/830881/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Societies Release Updated Guidelines for the Management of Atrial Fibrillation</title>
            
            
            <description>In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.</description>
            
            <link>https://www.clinicaladvisor.com/updated-aha-acc-hrs-guidelines-for-managing-atrial-fibrillation/article/830883/</link>
            <pubDate>Fri, 01 Feb 2019 14:00:00 GMT</pubDate>
            
          <itunes:summary>In order to revise the guidelines, the Task Force reviewed clinical trials presented at the annual scientific meetings of the ACC, AHA, HRS, and European Society of Cardiology in addition to other peer-reviewed, published data.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/updated-aha-acc-hrs-guidelines-for-managing-atrial-fibrillation/article/830883/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Apixaban in Patients With ESRD and Atrial Fibrillation </title>
            
            
            <description>There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation.</description>
            
            <link>https://www.clinicaladvisor.com/apixaban-in-patients-with-esrd-and-atrial-fibrillation/article/830398/</link>
            <pubDate>Wed, 30 Jan 2019 15:57:22 GMT</pubDate>
            
          <itunes:summary>There are limited published data on the efficacy and safety of direct-acting oral anticoagulants (DOACs) in patients with end-stage renal disease (ESRD) on dialysis and atrial fibrillation.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/apixaban-in-patients-with-esrd-and-atrial-fibrillation/article/830398/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Assessment of Dual Antiplatelet Therapy After Stroke, TIA </title>
            
            
            <description>Questions about the generalizability of previous data on dual antiplatelet therapy after minor ischemic stroke or high-risk transient ischemic attack lead investigators of the POINT trial to conduct a similar study in an international population.</description>
            
            <link>https://www.clinicaladvisor.com/assessment-of-dual-antiplatelet-therapy-after-stroke-tia/article/830397/</link>
            <pubDate>Wed, 30 Jan 2019 15:33:49 GMT</pubDate>
            
          <itunes:summary>Questions about the generalizability of previous data on dual antiplatelet therapy after minor ischemic stroke or high-risk transient ischemic attack lead investigators of the POINT trial to conduct a similar study in an international population.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/assessment-of-dual-antiplatelet-therapy-after-stroke-tia/article/830397/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Albiglutide Reduces Major CV Events in Patients With Type II Diabetes and Known CVD</title>
            
            
            <description>Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide.</description>
            
            <link>https://www.clinicaladvisor.com/albiglutide-reduces-major-cv-events-in-patients-with-type-ii-diabetes-and-known-cvd/article/830395/</link>
            <pubDate>Wed, 30 Jan 2019 15:19:51 GMT</pubDate>
            
          <itunes:summary>Albiglutide is available in other countries, and this trial may serve as an impetus for its reintroduction in the United States, particularly if follow-up results show a survival advantage with albiglutide.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/albiglutide-reduces-major-cv-events-in-patients-with-type-ii-diabetes-and-known-cvd/article/830395/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Physical Therapy May Allow Patients With Meniscal Tears to Avoid Surgery</title>
            
            
            <description>Starting with physical therapy and having surgery only if that failed was as effective as immediate surgery in patients with osteoarthritis of the knee.</description>
            
            <link>https://www.clinicaladvisor.com/physical-therapy-may-allow-patients-with-meniscal-tears-to-avoid-surgery/article/830389/</link>
            <pubDate>Wed, 30 Jan 2019 14:33:30 GMT</pubDate>
            
          <itunes:summary>Starting with physical therapy and having surgery only if that failed was as effective as immediate surgery in patients with osteoarthritis of the knee.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/physical-therapy-may-allow-patients-with-meniscal-tears-to-avoid-surgery/article/830389/</guid>
               
                                
        </item>
  
        <item>
          
          <title>Stat Consult: Human Immunodeficiency Virus (HIV)</title>
            
            
            <description>Growing evidence supports starting individuals on antiretroviral therapy as soon as they are diagnosed with HIV to improve mortality rates.</description>
            
            <link>https://www.clinicaladvisor.com/stat-consult-human-immunodeficiency-virus-hiv/article/830304/</link>
            <pubDate>Tue, 29 Jan 2019 20:10:19 GMT</pubDate>
            
          <itunes:summary>Growing evidence supports starting individuals on antiretroviral therapy as soon as they are diagnosed with HIV to improve mortality rates.</itunes:summary>
          <itunes:author><![CDATA[Clinical Advisor]]></itunes:author>
            
            
            
            <guid>https://www.clinicaladvisor.com/stat-consult-human-immunodeficiency-virus-hiv/article/830304/</guid>
               
                                
        </item>
  
      </channel>
    </rss>  
  